Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy

Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy

Show other versions (1)

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128809/?tool=EBI

Similar Items

Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy
by: The Staff
Published: (2014-01-01)

Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy.
Published: (2014-01-01)

Correction: Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy.
Published: (2014-01-01)

Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.
by: Valli De Re, et al.
Published: (2014-01-01)

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.
by: Valli De Re, et al.
Published: (2015-01-01)

Editorial: HLA and KIR Diversity and Polymorphisms: Emerging Concepts
by: Martin Maiers, et al.
Published: (2021-05-01)

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.
by: Valli De Re, et al.
Published: (2015-01-01)

Improving selection of patients with metastatic colorectal cancer to benefit from cetuximab based on KIR genotypes
by: Enrique Aranda, et al.
Published: (2021-04-01)

KIR-HLA combinations and susceptibility to tuberculosis
by: farhad Shahsavar, et al.
Published: (2013-02-01)

Association of KIR-HLA interactions with diseases
by: Farhad Shahsavar, et al.
Published: (2011-12-01)

KIR/HLA Interactions and Pathogen Immunity
by: Khaleel M. Jamil, et al.
Published: (2011-01-01)

Combination chemotherapy for metastatic colorectal cancer
by: Koehne Claus-Henning
Published: (2003-01-01)

PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH FIRST - LINE CHEMOTHERAPY
by: Deyan Davidov
Published: (2017-05-01)

Diversity of KIR/HLA Genotypes and Their Association with Psoriasis Vulgaris in the Western Mexican Population
by: Omar Graciano-Machuca, et al.
Published: (2020-03-01)

HLA-KIR Interactions and Immunity to Viral Infections
by: Masoud Sabouri Ghannad, et al.
Published: (2014-02-01)

A study of KIR binding to HLA-C
by: Fadda, Lena
Published: (2009)

Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.
by: Kouyuki Hirayasu, et al.
Published: (2012-01-01)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
by: Amy K. Erbe, et al.
Published: (2019-03-01)

Diverse functionality among NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
by: Achim K. Moesta, et al.
Published: (2012-11-01)

Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder
by: Anthony R Torres, et al.
Published: (2016-10-01)

Correction: comparative genomic analysis of primary and synchronous metastatic colorectal cancers.
by: PLOS ONE Staff
Published: (2015-01-01)

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy
by: Luciana Ribeiro Jarduli, et al.
Published: (2013-01-01)

Activating KIR/HLA complexes in classic Kaposi's Sarcoma
by: Guerini Franca R, et al.
Published: (2012-04-01)

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
by: Bożena Cybulska-Stopa, et al.
Published: (2020-03-01)

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
by: Yang Q, et al.
Published: (2015-09-01)

Metastatic Colorectal Cancer Treated with Herbal Pharmacopuncture during FOLFIRI Chemotherapy: A Case Report
by: Jung-Woo Lee, et al.
Published: (2014-05-01)

Cost-Effectiveness Analysis of Chemotherapy for Metastatic Colorectal Cancer
by: Er-Jung Hsueh, et al.
Published: (2014)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
by: Chrissy H Roberts, et al.
Published: (2014-03-01)

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
by: Fanny Ledys, et al.
Published: (2018-11-01)

KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
by: Takeji Umemura, et al.
Published: (2019-11-01)

Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation.
by: Izabela Nowak, et al.
Published: (2012-01-01)

Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer.
by: Jaime Feliu, et al.
Published: (2015-01-01)

Diversity of KIR genes and their HLA-C ligands in Ugandan populations with historically varied malaria transmission intensity
by: Stephen Tukwasibwe, et al.
Published: (2021-02-01)

The role of KIR-HLA combination in hematopoietic stem cells transplantation
by: farhad Shahsavar, et al.
Published: (2012-03-01)

Comparison of KIR/HLA genotypic analysis in the Lur and Iranian populatins
by: farhad shahsavar, et al.
Published: (2013-09-01)

The impact of KIR/HLA genes on the risk of developing multibacillary leprosy.
by: Hugo Vicentin Alves, et al.
Published: (2019-09-01)

KIR-HLA class I combinations in JIA-associated uveitis
by: Parsa Miriam, et al.
Published: (2012-07-01)

The influence of HLA-C and KIR on natural killer cell function
by: Sim, Malcolm John Wyness
Published: (2015)

Kir-hla genes and maternal infant HIV-1 transmission
by: Hong, Heather Alanna
Published: (2015)

Pharmacoeconomic-guided choice of systemic chemotherapy in metastatic colorectal cancer patients
by: M. Yu. Fedyanin, et al.
Published: (2017-09-01)

Cannot write session to /tmp/vufind_sessions/sess_s97vkk4pj0e5mnod9cot9224v4